How BPC-157 and NAD⁺ Help Support Mood and Energy During the Winter Months
As winter sets in and daylight becomes scarce, many people notice a familiar shift: lower energy, heavier moods, slower mornings, and a sense that motivation takes more effort than it used to. For some, this shows up as the “winter blues.” For others, it resembles a milder form of Seasonal Affective Disorder (SAD).¹
What’s important to understand is that this seasonal slump isn’t a character flaw or a lack of discipline — it’s biology. Reduced sunlight alters circadian rhythms, neurotransmitter activity, and cellular energy production in ways that directly affect how we feel and function.¹
Lifestyle strategies such as morning light exposure, movement, and consistent sleep remain foundational. At the same time, research interest has grown around two bioactive compounds — BPC-157 and NAD⁺ — for how they support the underlying systems that influence mood, resilience, and mental energy during darker months.
One is a regulatory peptide. The other is a foundational cellular cofactor. Together, they address two common winter bottlenecks: signal quality and energy availability.
1. BPC-157: Supporting Neurotransmitter Balance Through the Gut–Brain Connection
BPC-157 (Body Protection Compound-157) is a short peptide originally identified in human gastric juice. Early research focused on its ability to protect and repair the gut lining, blood vessels, and connective tissue.²⁻⁴ Over time, scientists noticed something else: changes in behavior, stress response, and neurotransmitter signaling.
This connection makes sense. The gut and brain are tightly linked through immune signaling, vagal communication, and shared neurotransmitter pathways.
How BPC-157 may support mood-related biology
Dopamine signaling support
Dopamine plays a central role in motivation, reward, and the ability to feel pleasure. In several animal models, BPC-157 has been shown to protect dopamine-producing neurons and help normalize dopamine receptor signaling after stress or chemical disruption.⁵⁻⁷
In practical terms, this matters because winter-related low mood often feels less like sadness and more like flatness — reduced drive, blunted enjoyment, and mental fatigue.
Serotonin modulation
Serotonin influences mood stability, anxiety, and emotional flexibility. Preclinical studies suggest BPC-157 can influence serotonin synthesis and turnover in a region-specific way — increasing availability in areas tied to reward and movement while stabilizing signaling in regions involved in stress response.⁸⁻¹⁰
Rather than overstimulating the system, the effect appears regulatory and balancing.
Stress-coping behavior
In validated behavioral models used to assess antidepressant-like activity, including the Porsolt forced swim test, BPC-157 produced improvements in stress-coping behavior comparable to reference compounds — without sedation or motor impairment.¹¹⁻¹³
This pattern suggests improved resilience rather than artificial stimulation.
2. NAD⁺: The Cellular Energy Behind Mental Clarity
NAD⁺ (nicotinamide adenine dinucleotide) is not a peptide. It is a coenzyme found in every cell of the body and is essential for converting nutrients into usable cellular energy (ATP), repairing DNA, and coordinating stress responses.¹⁴⁻¹⁶
When NAD⁺ levels decline, people often experience fatigue, brain fog, and reduced stress tolerance — symptoms that tend to worsen during winter months.
How NAD⁺ supports mood-related physiology
Neurotransmitter production
NAD⁺ is required for several enzymatic steps involved in producing dopamine, serotonin, and norepinephrine.¹⁷ Even when precursor nutrients are present, low NAD⁺ can limit output — much like having ingredients without a functioning stove.
Circadian rhythm stability
NAD⁺ levels fluctuate in sync with the body’s internal clock and directly interact with sirtuin enzymes within the brain’s circadian control center (the suprachiasmatic nucleus).¹⁸⁻²⁰ Supporting NAD⁺ availability may help maintain sleep–wake timing and daytime alertness when winter light cues are inconsistent.
Observed mental benefits
Clinical and translational research on NAD⁺ repletion strategies has reported improvements in fatigue, anxiety, and depressive symptom scores, with some data suggesting a dose-dependent relationship between restored cellular energy and improved mood outcomes.²¹⁻²³
In simple terms: when cells have enough energy, the brain has more capacity to cope.
3. The Stress–NAD⁺ Tug-of-War
One reason winter stress feels heavier is the way stress competes with energy at the cellular level.
When the body experiences chronic stress — from cold exposure, illness, disrupted sleep, or psychological load — it activates DNA-repair enzymes such as poly(ADP-ribose) polymerases (PARPs). These enzymes are protective, but they consume large amounts of NAD⁺ in the process.²⁴⁻²⁶
The drain effect
Stress quietly diverts NAD⁺ away from energy production and neurotransmitter support toward emergency cellular repair.
The downward spiral
As NAD⁺ availability drops, mental energy and stress tolerance decline — which makes everyday stressors feel more overwhelming, accelerating the cycle.
A helpful analogy is discretionary income. In calm periods, NAD⁺ can be “spent” on energy, focus, and mood. Under chronic stress, that same budget gets rerouted into emergency repairs, leaving little left for quality-of-life functions.
Restoring NAD⁺ availability helps rebuild this buffer.
4. How BPC-157 and NAD⁺ Complement Each Other
| Feature | BPC-157 | NAD⁺ |
| What it is | Regulatory peptide | Cellular coenzyme |
| Primary role | Neurotransmitter balance, gut–brain signaling | Mitochondrial energy, DNA repair |
| Key pathways | Dopamine, serotonin, angiogenic signaling | ATP production, sirtuins, PARP balance |
| Most helpful for | Emotional flatness, stress sensitivity | Brain fog, fatigue, circadian disruption |
Rather than overlapping, these compounds address different bottlenecks. One improves signal clarity. The other improves energy supply.
5. Who This Educational Information May Be Most Relevant For
Research interest has been strongest in individuals who experience:
- Seasonal drops in motivation or emotional resilience
- High stress combined with mental fatigue
- Gut-related symptoms that coincide with low mood
- Reduced energy and recovery capacity during winter months
These compounds are best viewed as supportive tools, intended to work alongside foundational habits such as light exposure, physical activity, nutrition, and sleep.
Educational Disclaimer
This article is for educational and informational purposes only. The compounds discussed are not approved by the U.S. Food and Drug Administration for the diagnosis, treatment, or prevention of mood disorders or seasonal affective disorder. Human clinical data remain limited, and findings cited include preclinical and observational research. Individuals should consult a qualified healthcare professional before considering any intervention.
References:
- Rosenthal NE, et al. Seasonal affective disorder: A description of the syndrome and preliminary findings. Arch Gen Psychiatry. 1984.
- Sikiric P, et al. Stable gastric pentadecapeptide BPC-157: First clinical applications and review. Curr Pharm Des. 2011.
- Sikiric P, et al. Gastrointestinal and systemic effects of BPC-157. J Physiol Pharmacol. 2014.
- Seiwerth S, et al. BPC-157 and tissue healing. Curr Pharm Des. 2013.
- Hranjec M, et al. Dopaminergic system protection by BPC-157. Behav Brain Res. 2015.
- Strbe S, et al. BPC-157 reverses dopamine system disturbances. Neuropharmacology. 2017.
- Klicek R, et al. Central nervous system effects of BPC-157. Brain Res. 2013.
- Vlainic J, et al. Serotonergic modulation by BPC-157. J Neural Transm. 2014.
- Zemba Cilic A, et al. Region-specific neurotransmitter effects of BPC-157. Neuroscience. 2019.
- Perovic D, et al. Anxiety-related behavior and BPC-157. Psychopharmacology. 2017.
- Porsolt RD, et al. Behavioral despair in rodents. Eur J Pharmacol. 1977.
- Sikiric P, et al. Antidepressant-like effects of BPC-157. Behav Brain Res. 2010.
- Kraljevic S, et al. Stress coping and BPC-157. Neuropsychopharmacology. 2012.
- Verdin E. NAD⁺ metabolism and aging. Cell. 2015.
- Covarrubias AJ, et al. NAD⁺ decline and mitochondrial dysfunction. Nat Rev Mol Cell Biol. 2021.
- Yoshino J, et al. NAD⁺ intermediates and human metabolism. Cell Metab. 2018.
- Braidy N, et al. NAD⁺ and neurotransmitter synthesis. Brain Res Rev. 2011.
- Ramsey KM, et al. Circadian NAD⁺ regulation. Science. 2009.
- Nakahata Y, et al. Sirtuins, NAD⁺, and the circadian clock. Cell. 2009.
- Peek CB, et al. NAD⁺ links circadian rhythms and metabolism. Nature. 2013.
- Grant R, et al. NAD⁺ repletion and mental fatigue. J Clin Psychopharmacol. 2019.
- Dellinger RW, et al. NAD⁺ metabolite supplementation outcomes. Nutrients. 2017.
- Martens CR, et al. Chronic NAD⁺ augmentation in adults. Nat Commun. 2018.
- Bai P, et al. PARP-1 and NAD⁺ depletion. Mol Cell. 2011.
- Cantó C, et al. NAD⁺, sirtuins, and cellular stress. Physiol Rev. 2015.
- Fouquerel E, Sobol RW. PARP-mediated DNA repair and metabolism. Trends Biochem Sci. 2014.